[Form 4] Weyco Group Inc Insider Trading Activity

Rhea-AI Filing Summary

Thomas W. Florsheim, Sr., a director of Weyco Group Inc. (WEYS), reported multiple transactions in the issuer's common stock on 08/25/2025 and 08/26/2025. The filing shows an acquisition of 1,890 shares on 08/25/2025 and additional reported adjustments on both dates that changed his direct beneficial ownership to 3,880 shares (direct). He also holds 554,173 shares indirectly in a revocable trust and 77,688 shares indirectly held by his wife. The form lists outstanding stock options exercisable into common stock (several tranches of 3,500 shares and one of 2,000 shares) with exercise prices ranging from $18.00 to $37.22 and expiration dates between 2027 and 2033.

Positive

• Director purchased shares (1,890 shares acquired on 08/25/2025), showing continued direct investment in WEYS
• Substantial indirect ownership retained in a revocable trust (554,173 shares) and by spouse (77,688 shares), aligning interests with company performance
• Clear option schedule with exercisable tranches through 2033 provides transparency on potential future share issuance

Negative

• None.

Insights

Financial Analyst

TL;DR: Director acquired shares and extensive indirect holdings dominate total ownership, while multiple long-dated option tranches remain outstanding.

These Form 4 entries record a modest direct purchase (1,890 shares) and a series of bookkeeping or transfer entries on 08/25/2025 and 08/26/2025 that result in 3,880 shares held directly and substantial indirect holdings of 554,173 shares in a revocable trust plus 77,688 shares held by spouse. The presence of multiple stock option tranches exercisable through 2033 indicates additional potential common shares from executive compensation, with exercise prices from $18.00 to $37.22. The transactions appear to be insider ownership adjustments and routine option schedules rather than a single large market-moving trade.

Corporate Governance Expert

TL;DR: Director maintains concentrated family and trust ownership; recorded small open-market or plan purchases and standard option vesting schedules.

The filing documents that Thomas W. Florsheim, Sr. remains materially invested indirectly through a revocable trust and spouse holdings, which can align his interests with shareholders. Reported option grants span 2018–2024 with 5-year vesting schedules noted in the explanations, and multiple tranches remain exercisable. The filing is consistent with routine disclosures required under Section 16 and shows no explicit departures, forfeitures, or unusual dispositions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FLORSHEIM THOMAS W

(Last) (First) (Middle)

333 W. ESTABROOK BOULEVARD

(Street)

GLENDALE WI 53212

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WEYCO GROUP INC [ WEYS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2025		A		1,890	A	$0	4,940	D
Common Stock	08/25/2025		Z		750	D	$0	4,190	D
Common Stock	08/25/2025		Z		750	A	$0	553,863	I	Held in Revocable Trust
Common Stock	08/26/2025		Z		310	D	$0	3,880	D
Common Stock	08/26/2025		Z		310	A	$0	554,173	I	Held in Revocable Trust
Common Stock								77,688	I	By Wife

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$27.94							08/25/2018(1)	08/25/2027	Common Stock	3,500		3,500	D
Stock Option	$37.22							08/23/2019(2)	08/23/2028	Common Stock	2,000		2,000	D
Stock Option	$23.38							08/14/2020(3)	08/14/2029	Common Stock	3,500		3,500	D
Stock Option	$18							08/26/2021(4)	08/26/2030	Common Stock	3,500		3,500	D
Stock Option	$24							08/25/2022(5)	08/25/2031	Common Stock	3,500		3,500	D
Stock Option	$28.83							08/25/2023(6)	08/25/2032	Common Stock	3,500		3,500	D
Stock Option	$25.79							08/25/2024(7)	08/25/2033	Common Stock	3,500		3,500	D

Explanation of Responses:

1. 20% per year for 5 years beginning 08/25/2018

2. 20% per year for 5 years beginning 08/23/2019

3. 20% per year for 5 years beginning 08/14/2020

4. 20% per year for 5 years beginning 08/26/2021

5. 20% per year for 5 years beginning 08/25/2022

6. 20% per year for 5 years beginning 08/25/2023

7. 20% per year for 5 years beginning 08/25/2024

	/s/ Thomas W. Florsheim, Sr.	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for WEYS and what is their role?

The filing was submitted by Thomas W. Florsheim, Sr., who is listed as a director of Weyco Group Inc.

What trades did the reporting person make on 08/25/2025 and 08/26/2025?

On 08/25/2025 the filing reports an acquisition of 1,890 shares and other reported adjustments; on 08/26/2025 it shows additional reported adjustments of 310 shares affecting direct holdings.

How many shares does Thomas W. Florsheim, Sr. beneficially own after these transactions?

Following the reported transactions he beneficially owns 3,880 shares directly, 554,173 shares indirectly in a revocable trust, and 77,688 shares indirectly held by his wife.

What derivative securities are reported on this Form 4?

The form lists multiple outstanding stock options: six tranches of 3,500 shares each and one tranche of 2,000 shares, exercisable into common stock with exercise prices from $18.00 to $37.22 and expirations between 2027 and 2033.

Do the explanations indicate vesting schedules for the options?

Yes, the explanations state a 20% per year for 5 years vesting pattern for each listed option tranche, with vesting start dates noted for each grant year.